Does DEUTETRABENAZINE Cause Therapy cessation? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Therapy cessation have been filed in association with DEUTETRABENAZINE (Austedo). This represents 1.1% of all adverse event reports for DEUTETRABENAZINE.
65
Reports of Therapy cessation with DEUTETRABENAZINE
1.1%
of all DEUTETRABENAZINE reports
1
Deaths
18
Hospitalizations
How Dangerous Is Therapy cessation From DEUTETRABENAZINE?
Of the 65 reports, 1 (1.5%) resulted in death, 18 (27.7%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEUTETRABENAZINE. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does DEUTETRABENAZINE Cause?
Drug ineffective (865)
Depression (437)
Dyskinesia (370)
Death (355)
Tremor (287)
Product use issue (286)
Somnolence (271)
Insomnia (264)
Suicidal ideation (259)
Fatigue (257)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which DEUTETRABENAZINE Alternatives Have Lower Therapy cessation Risk?
DEUTETRABENAZINE vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUTETRABENAZINE vs DEVICE
DEUTETRABENAZINE vs DEXAMETHASONE
DEUTETRABENAZINE vs DEXAMETHASONE\DEXAMETHASONE
DEUTETRABENAZINE vs DEXAMETHASONE\NEOMYCIN